UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 195

Sortiert nach

Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases

Gut, 2018-09, Vol.67 (9), p.1726

2018

Link zum Volltext

Verfügbarkeit prüfen

A review on human fecal metabolomics: Methods, applications and the human fecal metabolome database

Analytica chimica acta, 2018-11, Vol.1030, p.1-24

2018

Link zum Volltext

Verfügbarkeit prüfen

Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial

Gastroenterology (New York, N.Y. 1943), 2019-08, Vol.157 (2), p.440-450.e8

2019

Link zum Volltext

Verfügbarkeit prüfen

Growth Delay in Inflammatory Bowel Diseases: Significance, Causes, and Management

Digestive diseases and sciences, 2021-04, Vol.66 (4), p.954-964

2021

Link zum Volltext

Verfügbarkeit prüfen

Building Fences: How A20 Protects the Intestinal Mucosa in Inflammatory Bowel Diseases

Digestive diseases and sciences, 2020-05, Vol.65 (5), p.1288-1290

2020

Link zum Volltext

Verfügbarkeit prüfen

The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It

Cancers, 2018-03, Vol.10 (3), p.83

2018

Link zum Volltext

Verfügbarkeit prüfen

When Aspirin Causes Damage—Microbes Modulate the Host to Restore Gut Homeostasis

Gastroenterology (New York, N.Y. 1943), 2024-06, Vol.166 (6), p.1192-1192

Wine, Eytan

2024

Link zum Volltext

Verfügbarkeit prüfen

Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases

Frontiers in pediatrics, 2018-10, Vol.6, p.317-317

2018

Link zum Volltext

Verfügbarkeit prüfen

Host-Microbial Battle for Iron: New Opportunities to Combat Infection?

Gastroenterology (New York, N.Y. 1943), 2024-04, Vol.166 (4), p.712-712

Wine, Eytan

2024

Link zum Volltext

Verfügbarkeit prüfen

Could Gut and Food-Derived Yeast Be Responsible for Activating T Cells in Crohn's Disease?

Gastroenterology (New York, N.Y. 1943), 2024-02, Vol.166 (2), p.351-352

Wine, Eytan

2024

Link zum Volltext

Verfügbarkeit prüfen

Not All Fibers Are Born Equal; Variable Response to Dietary Fiber Subtypes in IBD

Frontiers in pediatrics, 2021-01, Vol.8, p.620189-620189

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacomicrobiomics in IBD: Should We Select Treatments Based on Gut Microbes?

Gastroenterology (New York, N.Y. 1943), 2023-09, Vol.165 (3), p.802-803

Wine, Eytan

2023

Link zum Volltext

Verfügbarkeit prüfen

Can Microbes and Their Components Prevent Growth Failure Caused by Malnutrition?

Gastroenterology (New York, N.Y. 1943), 2023-07, Vol.165 (1), p.303-303

Wine, Eytan

2023

Link zum Volltext

Verfügbarkeit prüfen

Eliminating Pathobionts With Bacteriophages: A Novel Approach to Reduce Gut Inflammation in Inflammatory Bowel Diseases?

Gastroenterology (New York, N.Y. 1943), 2023-02, Vol.164 (2), p.304-304

Wine, Eytan

2023

Link zum Volltext

Verfügbarkeit prüfen

Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome

PloS one, 2013-04, Vol.8 (4), p.e62220

2013

Link zum Volltext

Verfügbarkeit prüfen

Engineering Microbes to Combat Antibiotic-induced Dysbiosis: Implications for Gastroenterology

Gastroenterology (New York, N.Y. 1943), 2022-12, Vol.163 (6), p.1712-1712

Wine, Eytan

2022

Link zum Volltext

Verfügbarkeit prüfen

Expanding Links Between Gut Microbiota and Bowel Inflammation

Gastroenterology (New York, N.Y. 1943), 2022-07, Vol.163 (1), p.333-334

Wine, Eytan

2022

Link zum Volltext

Verfügbarkeit prüfen

S750 Defining Transition Success in Inflammatory Bowel Disease According to Patients, Parents, and Health Care Providers

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S346-S346

2021

Link zum Volltext

Verfügbarkeit prüfen

Nigericin Promotes NLRP3-Independent Bacterial Killing in Macrophages

Frontiers in immunology, 2019-10, Vol.10, p.2296-2296

2019

Link zum Volltext

Verfügbarkeit prüfen

Infliximab in young paediatric IBD patients: it is all about the dosing

European journal of pediatrics, 2020-12, Vol.179 (12), p.1935-1944

2020

Link zum Volltext

Verfügbarkeit prüfen

Parents’ Experiences and Information Needs While Caring for a Child With Functional Constipation: A Systematic Review

Clinical pediatrics, 2021-03, Vol.60 (3), p.154-169

2021

Link zum Volltext

Verfügbarkeit prüfen

Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease

Nutrients, 2021-12, Vol.14 (1), p.4

2021

Link zum Volltext

Verfügbarkeit prüfen

A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study

Nutrients, 2021-10, Vol.13 (11), p.3736

2021

Link zum Volltext

Verfügbarkeit prüfen

Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]

Journal of Crohn's and colitis, 2017-12, Vol.11 (12), p.1407-1419

2017

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort Study

The American journal of gastroenterology, 2024-03, Vol.119 (3), p.565-575

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(181)

Publikationsform

Sprache

Englisch
(195)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases

A review on human fecal metabolomics: Methods, applications and the human fecal metabolome database

Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial

Growth Delay in Inflammatory Bowel Diseases: Significance, Causes, and Management

Building Fences: How A20 Protects the Intestinal Mucosa in Inflammatory Bowel Diseases

The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It

When Aspirin Causes Damage—Microbes Modulate the Host to Restore Gut Homeostasis

Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases

Host-Microbial Battle for Iron: New Opportunities to Combat Infection?

Could Gut and Food-Derived Yeast Be Responsible for Activating T Cells in Crohn's Disease?

Not All Fibers Are Born Equal; Variable Response to Dietary Fiber Subtypes in IBD

Pharmacomicrobiomics in IBD: Should We Select Treatments Based on Gut Microbes?

Can Microbes and Their Components Prevent Growth Failure Caused by Malnutrition?

Eliminating Pathobionts With Bacteriophages: A Novel Approach to Reduce Gut Inflammation in Inflammatory Bowel Diseases?

Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome

Engineering Microbes to Combat Antibiotic-induced Dysbiosis: Implications for Gastroenterology

Expanding Links Between Gut Microbiota and Bowel Inflammation

S750 Defining Transition Success in Inflammatory Bowel Disease According to Patients, Parents, and Health Care Providers

Nigericin Promotes NLRP3-Independent Bacterial Killing in Macrophages

Infliximab in young paediatric IBD patients: it is all about the dosing

Parents’ Experiences and Information Needs While Caring for a Child With Functional Constipation: A Systematic Review

Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease

A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study

Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]

Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort Study

Suchergebnisse filtern